Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism

Front Oncol. 2022 Oct 26:12:1038279. doi: 10.3389/fonc.2022.1038279. eCollection 2022.

¹ Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China and Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
² Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
³ Department of Dermatology, Peking University People's Hospital, Beijing, China.
⁴ Deparment of Radiotherapy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
⁵ Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.977348.].

Keywords: HCC; OIT3; arachidonic acid; biomarker; ferroptosis.